Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04956302 · TERMINATED
Trial details
- NCT number
- NCT04956302
- Sponsor
- Abdullah Khan
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2022-06-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.